The introduction of TGF-β1, commonly upregulated in IBD patients, to IEC-6 cells demonstrated direct targeting by miR-200b on ZEB1, a negative regulator of AJ formation and thus increased E-cadherin expression [200]. The gene discussed is CDH1; the disease is inflammatory bowel disease.